Denise Carter - Oct 26, 2023 Form 4 Insider Report for Quoin Pharmaceuticals, Ltd. (QNRX)

Role
Chief Operating Officer, Director
Signature
/s/ Denise Carter
Stock symbol
QNRX
Transactions as of
Oct 26, 2023
Transactions value $
$0
Form type
4
Date filed
10/30/2023, 04:06 PM
Previous filing
Jan 3, 2023
Next filing
Sep 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNRX Share Option (Right to Buy) Award $0 +81K $0.00 81K Oct 26, 2023 American Depositary Share 81K $5.75 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS.
F2 The option vests in four annual installments with 20% vesting on each of October 26, 2024, 2025 and 2026 and 40% vesting on October 26, 2027.